An acclaimed life sciences campus in Bridgewater with some 800,000 square feet of research, manufacturing and office space is on the market — with the potential to sell for $500 million.
Thor Equities has started construction in its plan to overhaul a 350,000-square-foot building in Jersey City, where it aims to create “lab-ready” space that will attract life sciences users.
An investment firm has expanded its New Jersey life sciences portfolio with the acquisition of a research facility in Somerset County, in a transaction arranged by Newmark Knight Frank.
The nation’s life sciences sector continues to expand, boosted by technological advancements, growing employment and a strong economy. While Boston and San Francisco remain the country’s main life sciences hub, their tightening inventory and constrained labor force has driven momentum south to the Garden State.
A joint venture is reaping the rewards of a plan to reposition a sprawling research and development complex in Bridgewater, having sold the campus for more than $150 million. All the while, the deal has cast a light on the allure of life sciences as a real estate investment class and the power of collaboration by brokers across multiple geographic markets.